Page 2 - Psyence Function News Today

Psyence Group Announces SEC Registration Filing with NASDAQ

August 2, 2023

VANCOUVER, British Columbia, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE:PSYG | OTCQB: PSYGF), a clinical-stage life science biotechnology...

United States British Columbia United Kingdom Michael Jordaan Psyence Biomed Marc Balkin

Source: globenewswire.com

Psyence Group Announces Closing of Fourth Tranche of Private Placement and Conversion of Convertible Debt Note

April 3, 2023

TORONTO, April 03, 2023 -- Psyence Group inc. , a life science biotechnology company pioneering the use of natural psychedelics in mental health and well-being, is pleased to announce that it has... | April 3, 2023

United Kingdom United States Katherine Murphy Canadian Securities Exchange Canadian Securities Exchange The Psyence Group

Source: marketscreener.com

Psyence Group Announces Closing of Fourth Tranche of Private Placement and Conversion of Convertible Debt Note

April 3, 2023

TORONTO, April 03, 2023 -- Psyence Group inc. , a life science biotechnology company pioneering the use of natural psychedelics in mental health and well-being, is pleased to announce that... | June 21, 2023

United States United Kingdom Katherine Murphy Psyence Group Inc Canadian Securities Exchange The Psyence Group

Source: marketscreener.com

Psyence Announces Business Combination between Wholly Owned

January 10, 2023

VANCOUVER, British Columbia, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE:PSYG | OTCQB: PSYGF), a life science biotechnology company...

United States United Kingdom British Columbia Psyence Biomed Katherine Murphy Marc Balkin

Source: globenewswire.com

Psyence Signs Letter of Intent with Australian CRO iNGENū

January 9, 2023

VANCOUVER, British Columbia, Jan. 08, 2023 (GLOBE NEWSWIRE) -- Psyence Group Inc (CSE:PSYG | OTCQB: PSYGF), a life science biotechnology company...

United States United Kingdom British Columbia Katherine Murphy Neil Maresky Pty Ltd

Source: globenewswire.com

GOODMIND™ Available for Sale in the United Kingdom and

November 29, 2022

TORONTO, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the “Company”), a life science biotechnology...

United States United Kingdom Cape Town Western Cape South Africa Anna Persaud

Source: globenewswire.com

Psyence Group Completes Export of Psilocybin Mushrooms to

September 29, 2022

TORONTO, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the “Company”) is pleased to announce that it has...

United States United Kingdom Katherine Murphy Psilo Pharma David Reckeweg Lecompte Neil Maresky

Source: globenewswire.com

Psyence Group Receives Phase IIa Clinical Trial Approval

September 19, 2022

TORONTO, Sept. 19, 2022 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) ("Psyence" or the "Company"), a life science biotechnology...

United Kingdom South Africa United States Katherine Murphy Tom Mcdonald Neil Maresky

Source: globenewswire.com